Public Health | Intellepedia

Pharmaceutical Regulatory Data Protection in India

This article analyses regulatory data protection in India under TRIPS and domestic law. It discusses the balance between originator protection and access to generic medicines, highlighting the implications for public health and the pharmaceutical industry.

Intellectual Property, Accessibility and Public health

This analysis explores the relationship between intellectual property, accessibility, and public health, with a focus on recent global developments amid COVID-19. It highlights key policy measures, compulsory licensing, and collaborative efforts to promote access to medical technologies.

Preference for Collaborative and Open COVID Innovation and Creativity

The post explores the preference for collaborative and open innovation during the COVID-19 crisis, detailing the decline in IP filings and the shift away from IP exclusivity. It analyses legal measures and global initiatives that promote sharing and accessibility for COVID-related technologies and research.

Coronavirus disease (COVID-19) advice for the public – World Health Organization (WHO)

This post shares WHO’s latest COVID-19 advice, covering prevention, safety, and guidance for those in affected areas. It highlights hand and respiratory hygiene, social distancing, and the importance of following official health instructions.

Dr. Jonas Salk – The True Humanitarian

Dr. Jonas Salk developed the polio vaccine and chose not to seek a patent, enabling worldwide access and saving millions of lives. His humanitarian approach set a precedent in medical innovation and public health.

Chapter VI. Compulsory Licensing & Local Working – Comprehending Apprehending or Apprehending Comprehension?

This post examines compulsory licensing in India, with emphasis on the local working requirement and its interpretation under Indian patent law. It discusses the legal debates surrounding the TRIPS agreement and the impact on pharmaceutical patents. The analysis is grounded in recent case law and policy submissions.

Smoking Without Smoke

This article explores the problem of smoking and passive smoking, emphasizing ongoing health risks despite legislative efforts. It also examines a patented smokeless smoking device designed to mitigate these risks through innovative technology.

UNDP Issues Guidelines For Pharmaceutical Patent Examination

The UNDP has issued new guidelines aimed at strengthening pharmaceutical patent examination with an emphasis on public health. The guidelines advocate for stricter standards and the use of TRIPS flexibilities to curb evergreening and improve access to medicines.

Extension of Waiver for Pharma Patents until 2033 A.D.

The WTO has extended the waiver on pharmaceutical patent enforcement for least developed countries until 2033. This move ensures continued access to affordable generics from India and highlights the ongoing tension between patient access and patent rights.

Roche loses again

The Indian Patent Office has revoked Roche’s Valganciclovir patent, emphasizing Section 3d and public interest. This decision strengthens access to medicines in India and curbs evergreening by pharmaceutical companies.